Items tagged with Hepatitis C
WHO announces forthcoming updates on co-administration of treatment for drug-resistant TB and hepatitis C (post)
9 April 2024 — In a Rapid Communication issued today, the World Health Organization (WHO) is announcing updates on co-administration of treatment for drug-resistant tuberculosis and hepatitis C (HCV). The evidence suggests that concomitant treatment for HCV and multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB) is feasible, with potential benefits outweighing the harms. Co-administration may increase MDR/RR-TB treatment success and reduce failures, losses to follow-up, and deaths. Adherence support for HCV treatment during MDR/RR-TB treatment is also acknowledged.
UNITAID approves grants of $160 million (post with simple image)
Breakthrough new medicines for drug-resistant TB to be made available for low- and middle-income countries as part of $160 million of new grants funded by UNITAID.
HIV i-Base/TAG: 2014 Pipeline Report (post with simple image)
Latest annual review on pipeline drugs for adults and children, strategies for cure and prevention for HIV, HCV, TB and vaccine research.
Report: Global State of Harm Reduction 2014 (post with simple image)
The report includes the latest estimates around the response to drug-related HIV, viral hepatitis and tuberculosis.
WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers (post with simple image)
New WHO Model List of Essential Medicines published; After about 45 years of scarce innovation for TB medicines, 5 new products are included in the List. Four of these, including bedaquiline and delamanid, target multidrug-resistant TB.
The Medicines Patent Pool releases independent feasibility studies on hepatitis C and tuberculosis (post with simple image)
As part of its ongoing consultation processes on the possibility of the Medicines Patent Pool (MPP) expanding into other disease areas, the organisation has published independent feasibility studies exploring the case for potential entry into hepatitis C and tuberculosis.
HIV i-Base/TAG: 2015 Pipeline Report (post with simple image)
Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.
WHO guidance on integrated care for people who inject drugs (post with simple image)
WHO consolidated guidelines: Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs
Lancet Series on HIV and related infections in prisoners (post with simple image)
Mass imprisonment of drug users driving global epidemics of HIV, hepatitis, and tuberculosis.
TAG condemns murderous White House-proposed 2018 budget cuts for health and research (post with simple image)
The full disclosure of President Trump's FY18 budget reaffirms the current administration's intention of scaling-back critical progress in programs and research made in the fight against HIV/AIDS, TB and HCV.
Page 2 of 3 · Total posts: 0
←First 1 2 3 Last→